
Keywords: Donor-specific antibodies; Chronic active antibody-mediated rejection; Kidney transplantation; Transplant glomerulopathy; Treatment; ABMR; antibody-mediated rejection; Anti-IL2R-ab; anti-interleukin-2 receptor antibody; ATG; anti-thymocyte globulin; CAABM